Literature DB >> 21913051

Myocardial viability testing: still viable after stich?

Robert O Bonow, Thomas A Holly.   

Abstract

Mesh:

Year:  2011        PMID: 21913051     DOI: 10.1007/s12350-011-9453-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

1.  Myocardial viability and survival in ischemic left ventricular dysfunction.

Authors:  Robert O Bonow; Gerald Maurer; Kerry L Lee; Thomas A Holly; Philip F Binkley; Patrice Desvigne-Nickens; Jaroslaw Drozdz; Pedro S Farsky; Arthur M Feldman; Torsten Doenst; Robert E Michler; Daniel S Berman; Jose C Nicolau; Patricia A Pellikka; Krzysztof Wrobel; Nasri Alotti; Federico M Asch; Liliana E Favaloro; Lilin She; Eric J Velazquez; Robert H Jones; Julio A Panza
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

2.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

3.  The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.

Authors:  James E Udelson; Camille A Pearte; Carey D Kimmelstiel; Mariusz Kruk; Joseph A Kufera; Sandra A Forman; Anna Teresinska; Bartosz Bychowiec; Jose Antonio Marin-Neto; Thomas Höchtl; Eric A Cohen; Paulo Caramori; Benita Busz-Papiez; Christopher Adlbrecht; Zygmunt P Sadowski; Witold Ruzyllo; Debra J Kinan; Gervasio A Lamas; Judith S Hochman
Journal:  Am Heart J       Date:  2011-03       Impact factor: 4.749

4.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

5.  Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.

Authors:  David Bello; Dipan J Shah; George M Farah; Silvia Di Luzio; Michele Parker; Maryl R Johnson; William G Cotts; Francis J Klocke; Robert O Bonow; Robert M Judd; Mihai Gheorghiade; Raymond J Kim
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

6.  Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.

Authors:  J G F Cleland; D J Pennell; S G Ray; A J Coats; P W Macfarlane; G D Murray; J Dalle Mule; Z Vered; A Lahiri
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

7.  Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Authors:  Frank F Seghatol; Dipan J Shah; Silvia Diluzio; David Bello; Maryl R Johnson; William G Cotts; Jenny A O'Donohue; Robert O Bonow; Mihai Gheorghiade; Vera H Rigolin
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

8.  The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

Authors:  Eric J Velazquez; Kerry L Lee; Christopher M O'Connor; Jae K Oh; Robert O Bonow; Gerald M Pohost; Arthur M Feldman; Daniel B Mark; Julio A Panza; George Sopko; Jean L Rouleau; Robert H Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12       Impact factor: 5.209

Review 9.  Hibernating myocardium: diagnosis and patient outcomes.

Authors:  Arend F L Schinkel; Jeroen J Bax; Don Poldermans; Abdou Elhendy; Roberto Ferrari; Shahbudin H Rahimtoola
Journal:  Curr Probl Cardiol       Date:  2007-07       Impact factor: 5.200

Review 10.  Stunning, hibernation, and assessment of myocardial viability.

Authors:  Paolo G Camici; Sanjay Kumak Prasad; Ornella E Rimoldi
Journal:  Circulation       Date:  2008-01-01       Impact factor: 29.690

View more
  1 in total

1.  Towards personalized myocardial viability testing: personal reflections.

Authors:  Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.